Orion Competitors
Analyzing Orion Biotech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Orion Biotech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Orion Biotech competition on your existing holdings.
Orion |
Orion Biotech Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Orion Biotech and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Orion and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Orion Biotech Opport does not affect the price movement of the other competitor.
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | TBSA | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | APTM | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | CRZN | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | BGSX | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | GVCI | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | FRON | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | TRTL | ||
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Orion Stock performing well and Orion Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Orion Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TBSA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| APTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CRZN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| BGSX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GVCI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FRON | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TRTL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Orion Biotech Competitive Analysis
The better you understand Orion Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Orion Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Orion Biotech's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
| Market Volatility (90 Days Market Risk) |
| Market Performance (90 Days Performance) |
| Odds of Financial Distress (Probability Of Bankruptcy) |
| Current Valuation (Equity Enterprise Value) |
| Buy or Sell Advice (Average Analysts Consensus) |
Trade Advice (90 Days Macroaxis Advice) |
| Current Ratio |
| Net Asset |
| EBITDA |
| Current Valuation |
| Price To Book |
| Retained Earnings |
| Current Asset |
| Beta |
| Number Of Employees |
| Shares Outstanding |
| Cash Flow From Operations |
| Total Debt |
| Return On Asset |
| Number Of Shares Shorted |
| Book Value Per Share |
| Current Liabilities |
| Total Asset |
| Short Ratio |
| Debt To Equity |
| Shares Owned By Institutions |
| Market Capitalization |
| Price To Earning |
| Net Income |
| Earnings Per Share |
| Shares Owned By Insiders |
| Working Capital |
| Cash And Equivalents |
| Cash Per Share |
Orion Biotech Competition Performance Charts
Five steps to successful analysis of Orion Biotech Competition
Orion Biotech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Orion Biotech Opport in relation to its competition. Orion Biotech's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Orion Biotech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Orion Biotech's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Orion Biotech Opport, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Orion Biotech position
In addition to having Orion Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Realty Funds Thematic Idea Now
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Orion Stock
If you are still planning to invest in Orion Biotech Opport check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orion Biotech's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |